Raia Drogasil SA Share Price Sao Paulo
Stocks
DROG3
BRDROGACNOR1
Drug Retailers
OTC Markets Traded|
End-of-day quote
Sao Paulo
|
||
| - BRL | - |
|
| 08-05 | Raia Drogasil S.A., Q2 2026 Earnings Call, Aug 05, 2026 | |
| 08-04 | Raia Drogasil S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 34.95B 6.82B 5.87B 5.52B 5.05B 9.44B 644B 9.46B 65.26B 25.32B 330B 25.62B 25.06B 1,065B | P/E 2026 * |
23.7x | P/E 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 43.24B 8.44B 7.26B 6.83B 6.24B 11.67B 797B 11.71B 80.73B 31.33B 409B 31.69B 30.99B 1,317B | EV / Sales 2026 * |
0.95x | EV / Sales 2027 * | 0.84x |
| Free-Float |
73.24% | Yield 2026 * |
1.83% | Yield 2027 * | 2.15% |
Last Transcript : Raia Drogasil SA
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 31/12/2024 | |
| Director of Finance/CFO | 63 | 28/04/2013 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 50 | 31/12/2024 | |
| Director/Board Member | - | - | |
Gilberto Lerio
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.25% | +3.25% | +17.52% | -25.83% | 6.82B | |
| -0.13% | -1.46% | +0.15% | +35.12% | 1.38B | |
| +0.26% | -9.73% | +9.98% | +18.86% | 549M | |
| +0.29% | -0.04% | -6.54% | +30.17% | 67.88M | |
| Average | +0.17% | -2.00% | +5.28% | +14.58% | 2.21B | |
| Weighted average by Cap. | +0.19% | +1.68% | +14.14% | -13.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45.45B 8.87B 7.63B 7.18B 6.56B 12.27B 838B 12.31B 84.87B 32.93B 430B 33.31B 32.58B 1,384B | 52B 10.15B 8.73B 8.22B 7.51B 14.04B 958B 14.08B 97.09B 37.68B 492B 38.11B 37.28B 1,584B |
| Net income | 1.5B 293M 252M 237M 217M 406M 27.69B 407M 2.81B 1.09B 14.21B 1.1B 1.08B 45.77B | 2.02B 394M 339M 319M 292M 545M 37.22B 547M 3.77B 1.46B 19.1B 1.48B 1.45B 61.52B |
| Net Debt | 8.28B 1.62B 1.39B 1.31B 1.2B 2.24B 153B 2.24B 15.46B 6B 78.31B 6.07B 5.94B 252B | 8.97B 1.75B 1.51B 1.42B 1.3B 2.42B 165B 2.43B 16.75B 6.5B 84.83B 6.58B 6.43B 273B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- RADL3 Stock
- DROG3 Stock
Select your edition
All financial news and data tailored to specific country editions
